Celyad
David Georges has an extensive background in finance and administration, having held various titles in reputable companies such as Celyad Oncology, DIAsource ImmunoAssays, Merck Group, Citi, and AXA. David obtained their Master in Finance from Louvain School of Management and a Master's degree in Economics from Université catholique de Louvain.
This person is not in any offices
Celyad
1 followers
Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat illnesses where cardiac ...